Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis
Public ClinicalTrials.gov record NCT04753034. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Vehicle-Controlled, Phase 2 Study of TER-101 Topical Ointment to Assess Efficacy and Safety in Subjects With Mild to Moderate Atopic
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Phase 2 study will assess efficacy, safety, and tolerability of TER-101 ointment and vehicle twice daily for 28 days in adult and adolescent subjects with mild to moderate atopic dermatitis.
Study identification
- NCT ID
- NCT04753034
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 63 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 18, 2021 (Actual)
- Primary completion
- May 3, 2021 (Actual)
- Completion
- May 3, 2021 (Actual)
- Last update posted
- Jul 26, 2022
2021
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teres Bio site 05 | Scottsdale | Arizona | 85255 | — |
| Teres Bio Site 04 | Encinitas | California | 92024 | — |
| Teres Bio Site 12 | North Miami Beach | Florida | 33162 | — |
| Teres Bio Site 10 | Tampa | Florida | 33613 | — |
| Teres Bio Site 02 | Clarksville | Indiana | 47129 | — |
| Teres Bio Site 01 | Louisville | Kentucky | 40241 | — |
| Teres Bio site 09 | Saint Joseph | Missouri | 64506 | — |
| Teres Bio Site 08 | High Point | North Carolina | 27262 | — |
| Teres Bio Site 11 | Wilmington | North Carolina | 28405 | — |
| Teres Bio Site 03 | College Station | Texas | 77845 | — |
| Teres Bio Site 06 | Pflugerville | Texas | 78660 | — |
| Teres Bio Site 07 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04753034, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 26, 2022 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04753034 live on ClinicalTrials.gov.